Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Views

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>

20 March 2012: George, We Need a Budget for Growth

By Stephen Caddick  Vice-Provost (Enterprise) at UCL
Abolishing the 50p tax rate, a mansion tax, slashing fuel duty - speculation has been rife in the last few weeks on the surprises which might be in this year's Budget.
More...

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>